Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Pediatric Campylobacter Infections Follow-up

  • Author: Jocelyn Y Ang, MD, FAAP, FIDSA; Chief Editor: Russell W Steele, MD  more...
 
Updated: Sep 30, 2015
 

Further Outpatient Care

See the list below:

  • Assess the resolution of illness and patient compliance with medication.
Next

Further Inpatient Care

See the list below:

  • Evaluate protracted cases of Campylobacter infection further to rule out other causes of fever, diarrhea, and sepsis.
  • Provide close monitoring and support in the intensive care unit for immunoreactive complications such as Guillain-Barré syndrome (GBS).
Previous
Next

Inpatient & Outpatient Medications

See the list below:

  • Rehydrate intravenously or orally.
  • Administer antibiotics as indicated.
Previous
Next

Transfer

See the list below:

  • Patients with immunoreactive complications such as GBS may require transfer to a chronic care facility for rehabilitation after their condition stabilizes.
Previous
Next

Complications

See the list below:

  • Guillain-Barré syndrome
    • GBS is a disorder of peripheral nerves and is characterized by ascending paralysis.
    • Strong evidence suggests an association between preceding C jejuni infection and GBS.[32] The antigenic similarity between specific regions (terminal tetrasaccharide) of lipopolysaccharide of C jejuni and human gangliosides (GM1) led to the concept of molecular mimicry.[33] This concept implies the sharing of homologous epitopes between the bacterial lipopolysaccharide and ganglioside surface components of the peripheral nerve. Immune response from simple C jejuni infection could induce antibodies that cross-react to the gangliosides and trigger GBS.
    • Other variants of GBS associated with c jejuni infection include the following:
      • Acute motor axonal neuropathy (AMAN), or Chinese paralytic syndrome, is characterized by a rapid onset of paralysis with progression to tetraplegia and respiratory failure and occurs in children in northern China during summer and fall.[34]
      • Fisher syndrome is characterized by ophthalmoplegia, areflexia, and cerebellar ataxia.
  • Reactive arthritis
    • Incidence and prevalence of Campylobacter- associated reactive arthritis varies among different reports, ranging from 0.6-24%.[35, 36]
    • Development of reactive arthritis has been associated with human leukocyte antigen (HLA)-B27 allele; in these individuals, the disease is more severe than in individuals without HLA-B27.[37] However, a more recent population-based study did not show the association.[38]
    • Arthritis starts a few days to several weeks after the episode of diarrhea. The course is usually self-limited, ranging from 1 week to several months (< 6 mo).[35]
  • Other infrequently reported complications are as follows:
Previous
Next

Prognosis

See the list below:

  • Most patients fully recover after C jejuni infection, with or without antibiotics.
  • Campylobacter septicemia in patients with immune deficiencies (including congenital hypogammaglobulinemia, acquired hypogammaglobulinemia, malnutrition, HIV) and in neonates is associated with a high mortality rate.
  • Even with plasmapheresis and intravenous immunoglobulin, as many as 20% of patients with GBS may require mechanical ventilation. Between 15% and 20% of all patients may develop severe neurologic deficit. GBS disease may result in mortality in 5-10% of all patients. Because GBS secondary to C jejuni may be more severe, the number of patients who require mechanical ventilation, experience severe neurologic sequelae, and die may also be higher.
  • Previously healthy persons infected with C fetus usually recover without sequelae. This infection may be lethal to patients with altered immune status and neonates. Prognosis for these patients depends on the early administration of fluids and appropriate antimicrobial therapy.
Previous
Next

Patient Education

See the list below:

  • Tips for preventing campylobacteriosis
    • Thoroughly cook all poultry products. If served undercooked poultry in a restaurant, return it for further cooking.
    • Wash hands with soap before and after handling raw foods of animal origin.
    • Prevent cross-contamination in the kitchen
      • Use separate cutting boards for foods of animal origin and other foods.
      • Carefully clean all cutting boards, countertops, and utensils with soap and hot water after preparing raw food of animal origin.
    • Avoid consuming unpasteurized milk[39] and untreated surface water.
    • Make sure that persons with diarrhea, especially children, carefully and frequently wash their hands with soap to reduce the risk of spreading infection.
    • Wash hands with soap after contact with pet feces.
Previous
 
Contributor Information and Disclosures
Author

Jocelyn Y Ang, MD, FAAP, FIDSA Associate Professor, Department of Pediatrics, Wayne State University School of Medicine; Consulting Staff, Division of Infectious Diseases, Children's Hospital of Michigan

Jocelyn Y Ang, MD, FAAP, FIDSA is a member of the following medical societies: American Academy of Pediatrics, Infectious Diseases Society of America, Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Coauthor(s)

Sharon Nachman, MD Professor of Pediatrics, Associate Dean for Research, Stony Brook University School of Medicine

Sharon Nachman, MD is a member of the following medical societies: American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Mark R Schleiss, MD Minnesota American Legion and Auxiliary Heart Research Foundation Chair of Pediatrics, Professor of Pediatrics, Division Director, Division of Infectious Diseases and Immunology, Department of Pediatrics, University of Minnesota Medical School

Mark R Schleiss, MD is a member of the following medical societies: American Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Society for Pediatric Research

Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD Clinical Professor, Tulane University School of Medicine; Staff Physician, Ochsner Clinic Foundation

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, Southern Medical Association

Disclosure: Nothing to disclose.

Additional Contributors

Itzhak Brook, MD, MSc Professor, Department of Pediatrics, Georgetown University School of Medicine

Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Medical Association, American Society for Microbiology, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases, Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, Society for Ear, Nose and Throat Advances in Children, American Federation for Clinical Research, Surgical Infection Society, Armed Forces Infectious Diseases Society

Disclosure: Nothing to disclose.

References
  1. Zilbauer M, Dorrell N, Wren BW, Bajaj-Elliott M. Campylobacter jejuni-mediated disease pathogenesis: an update. Trans R Soc Trop Med Hyg. 2008 Feb. 102(2):123-9. [Medline].

  2. Allos BM. Campylobacter jejuni Infections: update on emerging issues and trends. Clin Infect Dis. 2001 Apr 15. 32(8):1201-6. [Medline].

  3. CDC. Vital signs: incidence and trends of infection with pathogens transmitted commonly through food--foodborne diseases active surveillance network, 10 U.S. sites, 1996-2010. MMWR Morb Mortal Wkly Rep. 2011 Jun 10. 60(22):749-55. [Medline].

  4. Foodborne Diseases Active Surveillance Network (FoodNet). Trends in Foodborne Illness in the United States, 1996–2011. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/foodnet/data/trends/trends-2011.html. Accessed: March 7, 2013.

  5. Feierl G, Jelovcan S. Campylobacteriosis in Austria: situation and trends. Wien Klin Wochenschr. 2009. 121(3-4):103-7. [Medline].

  6. Nichols GL, Richardson JF, Sheppard SK, Lane C, Sarran C. Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and Wales between 1989 and 2011. BMJ Open. 2012. 2(4):[Medline]. [Full Text].

  7. Jafari F, Garcia-Gil LJ, Salmanzadeh-Ahrabi S, Shokrzadeh L, Aslani MM, Pourhoseingholi MA. Diagnosis and prevalence of enteropathogenic bacteria in children less than 5 years of age with acute diarrhea in Tehran children's hospitals. J Infect. 2009 Jan. 58(1):21-7. [Medline].

  8. Wang SC, Chang LY, Hsueh PR, et al. Campylobacter enteritis in children in northern Taiwan--a 7-year experience. J Microbiol Immunol Infect. 2008. 41(5):408-413.

  9. Soofi SB, Habib MA, von Seidlein L, et al. A comparison of disease caused by Shigella and Campylobacter species: 24 months community based surveillance in 4 slums of Karachi, Pakistan. J Infect Public Health. 2011 Mar. 4(1):12-21. [Medline].

  10. Yang JR, Wu HS, Chiang CS, Mu JJ. Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005. BMC Infect Dis. 2008. 8:151. [Medline].

  11. Gillespie IA, O'Brien SJ, Penman C, Tompkins D, Cowden J, Humphrey TJ. Demographic determinants for Campylobacter infection in England and Wales: implications for future epidemiological studies. Epidemiol Infect. 2008 Dec. 136(12):1717-25. [Medline].

  12. Samuel MC, Vugia DJ, Shallow S, et al. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999. Clin Infect Dis. 2004. 38 Suppl 3:S165-174.

  13. Coker AO, Isokpehi RD, Thomas BN, Amisu KO, Obi CL. Human campylobacteriosis in developing countries. Emerg Infect Dis. 2002 Mar. 8(3):237-44. [Medline].

  14. Sorokin M, Usein CR, Irimia M, Damian M. A laboratory-based survey of Campylobacter infections in Prahova County. Roum Arch Microbiol Immunol. 2007 Jul-Dec. 66(3-4):85-9. [Medline].

  15. Pacanowski J, Lalande V, Lacombe K, Boudraa C, Lesprit P, Legrand P. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis. 2008 Sep 15. 47(6):790-6. [Medline].

  16. Tee W, Mijch A. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Clin Infect Dis. 1998 Jan. 26(1):91-6. [Medline].

  17. Blaser MJ. Extraintestinal Campylobacter infections. West J Med. 1986 Mar. 144(3):353-4. [Medline].

  18. Uzoigwe C. Campylobacter infections of the pericardium and myocardium. Clin Microbiol Infect. 2005 Apr. 11(4):253-5. [Medline].

  19. Fujihara N, Takakura S, Saito T, Iinuma Y, Ichiyama S. A case of perinatal sepsis by Campylobacter fetus subsp. fetus infection successfully treated with carbapenem--case report and literature review. J Infect. 2006. 53(5):e199-202.

  20. Simor AE, Karmali MA, Jadavji T, Roscoe M. Abortion and perinatal sepsis associated with campylobacter infection. Rev Infect Dis. 1986 May-Jun. 8(3):397-402. [Medline].

  21. Krishnaswamy R, Sasidharan P, Rejjal A, Osba YA. Early onset neonatal sepsis with Campylobacter jejuni: a case report. Eur J Pediatr. 1991 Feb. 150(4):277-8. [Medline].

  22. Zambrano LD, Levy K, Menezes NP, Freeman MC. Human diarrhea infections associated with domestic animal husbandry: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg. 2014 Jun. 108 (6):313-25. [Medline].

  23. Gazaigne L, Legrand P, Renaud B, Bourra B, Taillandier E, Brun-Buisson C. Campylobacter fetus bloodstream infection: risk factors and clinical features. Eur J Clin Microbiol Infect Dis. 2008 Mar. 27(3):185-9. [Medline].

  24. Bessede E, Delcamp A, Sifre E, et al. New methods for detection of campylobacters in stool samples in comparison to culture. J Clin Microbiol. 2011 Mar. 49(3):941-4. [Medline].

  25. Mee AS, Shield M, Burke M. Campylobacter colitis: differentiation from acute inflammatory bowel disease. J R Soc Med. 1985 Mar. 78(3):217-23. [Medline].

  26. Ternhag A, Asikainen T, Giesecke J, Ekdahl K. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin Infect Dis. 2007 Mar 1. 44(5):696-700. [Medline].

  27. Alfredson DA, Korolik V. Antibiotic resistance and resistance mechanisms in Campylobacter jejuni and Campylobacter coli. FEMS Microbiol Lett. 2007 Dec. 277(2):123-32. [Medline].

  28. Valenza G, Frosch M, Abele-Horn M. Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008. Scand J Infect Dis. 2010. 42(1):57-60. [Medline].

  29. Ewnetu D, Mihret A. Prevalence and antimicrobial resistance of Campylobacter isolates from humans and chickens in Bahir Dar, Ethiopia. Foodborne Pathog Dis. 2010 Jun. 7(6):667-70. [Medline].

  30. Tremblay C, Gaudreau C. Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus. Antimicrob Agents Chemother. 1998 Jul. 42(7):1847-9. [Medline].

  31. Tremblay C, Gaudreau C, Lorange M. Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Quebec, Canada, from 1983 to 2000. J Clin Microbiol. 2003 Jan. 41(1):463-6. [Medline].

  32. Huizinga R, van Rijs W, Bajramovic JJ, Kuijf ML, Laman JD, Samsom JN, et al. Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-α. J Immunol. 2013 Dec 1. 191 (11):5636-45. [Medline].

  33. Yuki N. Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome. J Neurochem. 2007 Nov. 103 Suppl 1:150-8. [Medline].

  34. McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol. 1993 Apr. 33(4):333-42. [Medline].

  35. Pope JE, Krizova A, Garg AX, Thiessen-Philbrook H, Ouimet JM. Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum. 2007 Aug. 37(1):48-55. [Medline].

  36. Keithlin J, Sargeant J, Thomas MK, Fazil A. Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae. BMC Public Health. 2014 Nov 22. 14:1203. [Medline].

  37. Peterson MC. Rheumatic manifestations of Campylobacter jejuni and C. fetus infections in adults. Scand J Rheumatol. 1994. 23(4):167-70. [Medline].

  38. Hannu T, Mattila L, Rautelin H, Pelkonen P, Lahdenne P, Siitonen A. Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford). 2002 Mar. 41(3):312-8. [Medline].

  39. Committee on Infectious Diseases, Committee on Nutrition, American Academy of Pediatrics. Consumption of raw or unpasteurized milk and milk products by pregnant women and children. Pediatrics. 2014 Jan. 133 (1):175-9. [Medline].

  40. Blaser MJ, Perez GP, Smith PF, Patton C, Tenover FC, Lastovica AJ. Extraintestinal Campylobacter jejuni and Campylobacter coli infections: host factors and strain characteristics. J Infect Dis. 1986 Mar. 153(3):552-9. [Medline].

  41. Braun KP, Theissig F, Ernst H, May M, Krulls-Munch J. [Campylobacter-jejuni-associated hepatitis and myocardial injury]. Med Klin (Munich). 2008 May 15. 103(5):346-8. [Medline].

  42. [Guideline] Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. MMWR Recomm Rep. 2004 Apr 16. 53:1-33. [Medline].

  43. Godschalk PC, Kuijf ML, Li J, St et al. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect Immun. 2007. 75(3):1245-1254.

  44. Luquero Alcalde FJ, Sanchez Padilla E, Eiros Bouza JM, et al. [Trend and seasonal variations of Campylobacter gastroenteritis in Valladolid, Spain. A five-year series, 2000-2004]. Rev Esp Salud Publica. 2007. 81(3):319-326.

  45. Peterson MC. Clinical aspects of Campylobacter jejuni infections in adults. West J Med. 1994 Aug. 161(2):148-52. [Medline].

  46. Roan JN, Ko WC, Luo CY. Abdominal septic aortic pseudoaneurysm caused by Campylobacter jejuni infection: report of a case. Surg Today. 2009. 39(2):137-40. [Medline].

  47. Tokuda K, Nishi J, Miyanohara H, Sarantuya J, Iwashita M, Kamenosono A. Relapsing cellulitis associated with Campylobacter coli bacteremia in an agammaglobulinemic patient. Pediatr Infect Dis J. 2004 Jun. 23(6):577-9. [Medline].

Previous
Next
 
Scanning electron microscope image of Campylobacter jejuni, illustrating its corkscrew appearance and bipolar flagella. Source: Virginia-Maryland Regional College of Veterinary Medicine, Blacksburg, Virginia.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.